PM Group has recently completed concept design for a greenfield pharmaceutical facility to be developed by CJSC Vertex in Saint Petersburg, Russia.
Leading Russian pharmaceutical manufacturer CJSC Vertex is developing this new facility to produce medications for the treatment of cardiovascular, dermatological, gynaecological and other conditions.
The plant will be located on a 5 ha site in the Novoorlovskoe Special Economic Zone which is one of three ‘pharmaparks’ that form St Petersburg’s pharmaceutical cluster. The recent focus on high tech industry is a key strategy for the city’s economic development, and several companies including Novartis, JSC Pharmasintez, CJSC Immuno-Gem and CJSC Vertex are set to locate in the zone.
Construction is due to commence in 2012 and completion is due in 2014. The facility is expected to employ 800 people when complete.
The concept design for this complex facility was delivered by PM Group’s team of local and international specialists under the guidance of Project Manager George Gubanov and Senior Pharmaceutical Specialist Alexander Sharonov.